Drug-drug interaction prediction based on local substructure features and their complements

被引:1
作者
Zhou, Qing [1 ]
Zhang, Yang [1 ]
Wang, Siyuan [1 ]
Wu, Dayu [1 ]
机构
[1] Chongqing Univ, Coll Comp Sci, Chongqing 400044, Peoples R China
关键词
Drug-drug interactions; Multi-channel feature fusion; Multi-type interactions; Substructure interactions; Feature extraction;
D O I
10.1016/j.jmgm.2023.108557
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The properties of drugs may undergo changes when multiple drugs are co-administered to treat co-existing or complex diseases, potentially leading to unforeseen drug-drug interactions (DDIs). Therefore, predicting potential drug-drug interactions has been an important task in pharmaceutical research. However, the following challenges remain: (1) existing methods do not work very well in cold-start scenarios, and (2) the interpretability of existing methods is not satisfactory. To address these challenges, we proposed a multichannel feature fusion method based on local substructure features of drugs and their complements (LSFC). The local substructure features are extracted from each drug, interacted with those of another drug, and then integrated with the global features of two drugs for DDI prediction. We evaluated LSFC on two real-world DDI datasets in worm-start and cold-start scenarios. Comprehensive experiments demonstrate that LSFC consistently improved DDI prediction performance compared with the start-of-the-art methods. Moreover, visual inspection results showed that LSFC can detect crucial substructures of drugs for DDIs, providing interpretable DDI prediction. The source codes and data are available at https://github.com/Zhang-Yang-ops/LSFC.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Physiological approaches to the prediction of drug-drug interactions in study populations
    Chien, JY
    Mohutsky, MA
    Wrighton, SA
    CURRENT DRUG METABOLISM, 2003, 4 (05) : 347 - 356
  • [42] Evaluation of Contraindicated Drug-Drug Interaction Alerts in a Hospital Setting
    Hatton, Randy C.
    Rosenberg, Amy F.
    Morris, Candice T.
    McKelvey, Russell P.
    Lewis, James R.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (03) : 297 - 308
  • [43] Drug-drug interaction software in clinical practice: a systematic review
    Roblek, Tina
    Vaupotic, Tomaz
    Mrhar, Ales
    Lainscak, Mitja
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (02) : 131 - 142
  • [44] Physicians' responses to computerized drug-drug interaction alerts for outpatients
    Yeh, Min-Li
    Chang, Ying-Jui
    Wang, Po-Yen
    Li, Yu-Chuan
    Hsu, Chien-Yeh
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2013, 111 (01) : 17 - 25
  • [45] Improving the specificity of drug-drug interaction alerts: Can it be done?
    Reese, Thomas
    Wright, Adam
    Liu, Siru
    Boyce, Richard
    Romero, Andrew
    Del Fiol, Guilherme
    Kawamoto, Kensaku
    Malone, Daniel
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (13) : 1086 - 1095
  • [46] Checklist for standardized reporting of drug-drug interaction management guidelines
    Floor-Schreudering, Annemieke
    Geerts, Arjen F. J.
    Aronson, Jeffrey K.
    Bouvy, Marcel L.
    Ferner, Robin E.
    De Smet, Peter A. G. M.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (03) : 313 - 318
  • [47] Pediatric Drug-Drug Interaction Evaluation: Drug, Patient Population, and Methodological Considerations
    Gonzalez, Daniel
    Sinha, Jaydeep
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 : S175 - S187
  • [48] Transforming Drug-Drug Interaction Extraction from Biomedical Literature
    Zaikis, Dimitrios
    Kokkas, Stylianos
    Vlahavas, Ioannis
    PROCEEDINGS OF THE 12TH HELLENIC CONFERENCE ON ARTIFICIAL INTELLIGENCE, SETN 2022, 2022,
  • [49] Microdosing Cocktail Assay Development for Drug-Drug Interaction Studies
    Chavez-Eng, Cynthia M.
    Lutz, Ryan W.
    Goykhman, Dina
    Bateman, Kevin P.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (07) : 1973 - 1986
  • [50] Drug-drug interaction software in clinical practice: a systematic review
    Tina Roblek
    Tomaz Vaupotic
    Ales Mrhar
    Mitja Lainscak
    European Journal of Clinical Pharmacology, 2015, 71 : 131 - 142